Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Viridian Therapeutics, Inc.\DE (VRDN) Inventory: 2014-2016

Historic Inventory for Viridian Therapeutics, Inc.\DE (VRDN) over the last 3 years, with Dec 2016 value amounting to $64,000.

  • Viridian Therapeutics, Inc.\DE's Inventory fell 65.78% to $64,000 in Q4 2016 from the same period last year, while for Dec 2016 it was $64,000, marking a year-over-year decrease of 65.78%. This contributed to the annual value of $64,000 for FY2016, which is 65.78% down from last year.
  • Per Viridian Therapeutics, Inc.\DE's latest filing, its Inventory stood at $64,000 for Q4 2016, which was up 3.23% from $62,000 recorded in Q3 2016.
  • Over the past 5 years, Viridian Therapeutics, Inc.\DE's Inventory peaked at $536,000 during Q2 2015, and registered a low of $62,000 during Q3 2016.
  • Its 3-year average for Inventory is $239,019, with a median of $213,000 in 2016.
  • In the last 5 years, Viridian Therapeutics, Inc.\DE's Inventory skyrocketed by 177.52% in 2015 and then crashed by 82.97% in 2016.
  • Quarterly analysis of 3 years shows Viridian Therapeutics, Inc.\DE's Inventory stood at $179,000 in 2014, then increased by 4.47% to $187,000 in 2015, then crashed by 65.78% to $64,000 in 2016.
  • Its Inventory stands at $64,000 for Q4 2016, versus $62,000 for Q3 2016 and $213,000 for Q2 2016.